La malattia cardiovascolare nel paziente adulto sopravvissuto al cancro: una nuova frontiera per la cardio-oncologia
The enormous progress made in recent decades in the diagnosis and treatment of oncological and hematological diseases has resulted in a significant increase in patient survival and a substantial growth in the population of cancer survivors. These include both living patients with active disease and those who are free of cancer after treatment. There is strong evidence that cancer survivors are at an increased risk of developing cardiovascular diseases and that this risk may outweigh the prognostic impact that is imposed by the disease itself for certain types of cancer. The pathophysiological bases of the interaction between cardiovascular disease and cancer are complex and involve the sharing of both modifiable and non-modifiable risk factors, the effects on the cardiovascular system of certain treatments, as well as the pathogenic changes imposed by cancer, in which inflammation appears to play a key role. In this context, it is therefore essential to increase the attention of the cardiology community to this issue and to enhance cardiological follow-up programs for this high cardiovascular risk population.
Authors
- Massimo Grimaldi (ORCID: https://orcid.org/0000-0002-9347-8884)
- Daniela Aschieri (ORCID: https://orcid.org/0000-0002-1577-5402)
- Luigi Tarantini (ORCID: https://orcid.org/0000-0003-2580-0963)
- Alessandra Greco (ORCID: https://orcid.org/0000-0002-3130-0079)
- Claudio Bilato (ORCID: https://orcid.org/0000-0003-3474-0579)
- Furio Colivicchi (ORCID: https://orcid.org/0000-0001-7187-2234)
- Giovanna Geraci (ORCID: https://orcid.org/0000-0003-0092-8717)
- Alessandro Inno (ORCID: https://orcid.org/0000-0001-6331-6908)
- Stefano Oliva (ORCID: https://orcid.org/0000-0002-3200-2372)
- Nicola Maurea (ORCID: https://orcid.org/0000-0003-3704-0092)
- Carmine Riccio (ORCID: https://orcid.org/0000-0003-0160-3674)
- Andrea Tedeschi (ORCID: https://orcid.org/0000-0003-0315-3304)
- Fabrizio Oliva (ORCID: https://orcid.org/0000-0002-5827-996X)
- Maria Laura Canale (ORCID: https://orcid.org/0000-0003-0990-6397)
- Alessandro Navazio
- Irma Bisceglia
- Marzia De Biasio (ORCID: https://orcid.org/0000-0003-1873-1891)
Institutions
- Azienda Sanitaria Unità Locale di Reggio Emilia (IT)
- Azienda Ospedaliera San Camillo-Forlanini (IT)
- Associazione Nazionale Medici Cardiologi Ospedalieri (IT)
- AULSS 2 Marca Trevigiana (IT)
- Ospedale San Filippo Neri (IT)
- Ospedale Sacro Cuore Don Calabria (IT)
- Presidio Ospedaliero (IT)
- Azienda Ospedaliera S.Maria (IT)
- Ospedale Santa Maria della Misericordia di Udine (IT)
- Istituto Tumori Bari (IT)
- Guglielmo da Saliceto Hospital (IT)
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
- Ospedale Generale Regionale Francesco Miulli (IT)
- Ospedale Sant'Anna (IT)
- Policlinico San Matteo Fondazione (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Ospedale Versilia (IT)
- Azienda Sanitaria Universitaria Integrata di Trieste (IT)
Publication Details
- Journal
- Giornale italiano di cardiologia
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1714/4570.45737
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00